BioCentury
ARTICLE | Clinical News

MM-121: Phase II data

November 4, 2013 8:00 AM UTC

In August, Merrimack disclosed on a conference call to discuss its 2Q13 earnings that a pre-specified interim analysis of the trial by a DSMB showed that MM-121 plus paclitaxel would not meet the prim...